The report indicates that, over the next five years, the advancement in non-fusion spinal surgery techniques as well as evidence about the negative aspects of spinal fusion will prompt an expansion of non-fusion products. The analysis includes a study of crucial market drivers, challenges and trends impacting spine device manufacturers today.
Additionally, the report includes pricing analysis and a discussion of the market share and competitor structure.
Read the Frost & Sullivan release on the spine industry analysis.
Read other coverage on spine device companies:
– Boston Scientific Receives FDA Approval for Spinal Cord Stimulation Lead Splitters
– WSJ: Spine Device Manufacturers Feel the Pressure From Insurance Companies
– TranS1 Releases New System for Lumbar Fusion
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
